Refresh
X
Gainers
Losers
Sectors
Indices
Forex
Mutual Funds
Home
Indices
Sectors
Mutual Funds
Gainers
Losers
Forex
Investment Tool
All Pages
Anupam Rasayan India Ltd.
BSE
Price on BSE
10 Aug,15:27 LIVE
1,210.25
-1.40
(-0.12%)
© 2026 Rediff.com
Volume :
487.00
Prev Close :
1,211.65
Day's H/L (Rs.) :
1,217.65 - 1,209.05
52wk H/L (Rs.) :
1,415.40 - 1,047.40
Mkt Cap (Rs. Cr) :
13,772.65
NSE
Price on NSE
10 Aug,15:55 LIVE
1,216.30
+1.70
(+0.14%)
© 2026 Rediff.com
Volume :
73,071.00
Prev Close :
1,214.60
Day's H/L (Rs.) :
1,217.00 - 1,209.50
52wk H/L (Rs.) :
1,415.00 - 1,045.20
Mkt Cap (Rs. Cr) :
0.00
Report Card - Anupam Rasayan India Ltd.
PE Ratios
85.47
EPS (Rs.)
14.18
Sales (Rs. Cr)
370.58
Face Value (Rs.)
10
Net Profit Margin(%)
8.11
Last Bonus
-
Last Dividend(%)
15
Return on Average Equity
2.67
News for Anupam Rasayan India Ltd.
Anupam Rasayan Signs $300M Battery Chemical Deal with BasqueVolt
Anupam Rasayan India Ltd signs a non-binding LOI with Spain''s BasqueVolt SA for a 10-year supply of specialty chemicals, potentially generating $300M.
Jul 15, 2026 12:10
Anupam Rasayan: World''s First ETFA Flow Chemistry Production
Anupam Rasayan India Ltd. becomes the world''s first to commercialize Ethyl trifluoroacetate (ETFA) using proprietary continuous flow chemistry, enhancing safety & efficiency.
Jun 12, 2026 14:59
Anupam Rasayan to Acquire Stake in Bliss GVS Pharma
Anupam Rasayan to acquire up to 43% stake in Bliss GVS Pharma for Rs 1,369 cr. Open offer for additional 26%.
May 24, 2026 14:21
Anupam Rasayan Acquires Jayhawk for USD 150 Million
Anupam Rasayan completes USD 150 million acquisition of Jayhawk Fine Chemicals, expanding its global footprint and entering end-use markets.
Feb 27, 2026 19:21
Anupam Rasayan Q3 Profit Up 12% on Higher Revenue
Anupam Rasayan India reports 12% rise in Q3 net profit to Rs 61 crore. Revenue up 31.35%. Acquisition of Jayhawk Fine Chemicals announced.
Feb 14, 2026 16:06
More News for Anupam Rasayan India Ltd. »
News for Miscellaneous
LEAP India IPO: 49% Subscription on Day 2, Rs 2,480 Cr Issue
LEAP India''s Rs 2,480 crore IPO received 49% subscription on its second day. Learn about the issue size, price band, and investor details.
Aug 10, 2026 20:23
Triveni Turbine Q1 Net Profit Down 20%, Revenue Up
Triveni Turbine reports 20% drop in Q1 net profit to Rs 51.1 cr, despite revenue growth. Export and aftermarket order bookings show strong momentum.
Aug 10, 2026 20:12
Dhoot Transmission IPO Subscribed 63% on Day 1
Dhoot Transmission IPO subscribed 63% on Day 1. Retail quota 74%, non-institutional 1.09x. Anchor investors like BlackRock secured Rs 918.3 cr.
Aug 10, 2026 20:01
Bombay Dyeing Q1 FY27 Profit Declines 49% to Rs 7 Cr
Bombay Dyeing reports 48.73% profit decline to Rs 7.08 cr in Q1 FY27, despite 8.72% revenue growth. Shares down 0.17%.
Aug 10, 2026 20:00
Bosch Q1 Net Profit Drops 36.8%; Revenue Up, Auto Sector Drives Growth
Bosch Ltd reports 36.8% Q1 net profit decline to Rs 704.9 cr due to high base effect, despite revenue growth & strong demand in automotive & power solutions.
Aug 10, 2026 19:23
More News »
Top News
KEC International Q1 Net Profit Drops 41% to Rs 73 Cr
KEC International reports 41% net profit drop to Rs 73 Cr in Q1 FY27, with flat revenues. Despite challenges, the company maintains a strong order book and positive outlook.
Aug 10, 2026 20:44
Technocraft Ventures IPO Subscribed 4.73x on Day 2
Technocraft Ventures IPO received 4.73 times subscription on day 2, with strong interest from QIBs, retail, and non-institutional investors. The EPC firm''s IPO closes Tuesday.
Aug 10, 2026 20:28
Naresh Goyal: Discharge Plea in Jet Airways Money Laundering
Naresh Goyal, Jet Airways founder, seeks discharge from ED''s Rs 538.62 crore money laundering case. Court directs prosecution to reply to his plea.
Aug 10, 2026 20:25
LEAP India IPO: 49% Subscription on Day 2, Rs 2,480 Cr Issue
LEAP India''s Rs 2,480 crore IPO received 49% subscription on its second day. Learn about the issue size, price band, and investor details.
Aug 10, 2026 20:23
Jubilant Pharmova Q1 Net Profit Down 45% to Rs 56.4 Cr
Jubilant Pharmova reports 45% Q1 net profit decline to Rs 56.4 crore due to higher expenses & depreciation, despite strong revenue growth. Read more on financial results.
Aug 10, 2026 20:20
More Top News »
Sectoral Indices
Market Indicators
Listed Companies
Gainers
Losers
Mutual Funds
Portfolio
Watchlist